Disease | rheumatoid arthritis |
Symptom | |cardiovascular disease |
Sentences | 61 |
PubMedID- 23204310 | Atherosclerosis and cardiovascular disease in rheumatoid arthritis. |
PubMedID- 26082375 | Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 26117596 | Prevention of cardiovascular disease in rheumatoid arthritis. |
PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 21109513 | cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
PubMedID- 20952464 | Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. |
PubMedID- 23300117 | Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward). |
PubMedID- 26362702 | Risk factors for cardiovascular disease in rheumatoid arthritis patients from mato grosso do sul. |
PubMedID- 24498997 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 24795506 | Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score frs). |
Page: 1 2